These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11208444)

  • 1. Utility of the triple test in the detection of abnormalities of the feto-placental unit.
    Perenc M; Dudarewicz L; Kałuzewski B
    Med Sci Monit; 2000; 6(5):994-9. PubMed ID: 11208444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome].
    Liao S; Wang Y; Ye G
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal serum screening of fetal chromosomal abnormalities by AFP, UE3, hCG and free-beta hCG. Prospective and retrospective results.
    Valerio D; Aiello R; Altieri V; Fagnoni P
    Minerva Ginecol; 1996 May; 48(5):169-73. PubMed ID: 8783867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Noninvasive serum test for prenatal detection of Down syndrome, other chromosome abnormalities and open neural tube defects--a prospective study].
    Zwahr C; Voss P; Kistner G
    Geburtshilfe Frauenheilkd; 1994 Jun; 54(6):355-61. PubMed ID: 7522195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal serum screening for aneuploid pregnancy by alpha-fetoprotein, hCG, and unconjugated estriol.
    Heyl PS; Miller W; Canick JA
    Obstet Gynecol; 1990 Dec; 76(6):1025-31. PubMed ID: 1700348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of triple test results in 27 cases of twin pregnancies.
    Perenc M; Dudarewicz L; Kałuzewski B
    Acta Genet Med Gemellol (Roma); 1998; 47(3-4):249-54. PubMed ID: 10916570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prenatal maternal blood screening for the detection of fetal chromosomal abnormalities: clinical importance of the rate of false positives].
    Alvarez-Nava F; Soto M; Padrón T; Morales A; Villalobos D; Rojas de Atencio A; Prieto M; Martínez MC
    Invest Clin; 2003 Sep; 44(3):195-207. PubMed ID: 14552058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal serum triple analyte screening in pregnancy.
    Graves JC; Miller KE; Sellers AD
    Am Fam Physician; 2002 Mar; 65(5):915-20. PubMed ID: 11898965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sensitivity of the trivariate analysis using maternal serum alpha-feto protein, human chorionic gonadotrophin and maternal age in screening for fetal aneuploidy in mothers above the age of 35.
    Anandakumar C; Chew S; Wong YC; Goh VH; Tain CF; Ratnam SS
    J Perinat Med; 1999; 27(3):178-82. PubMed ID: 10503178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple marker screening test: identification of fetal cystic hygroma, hydrops, and sex chromosome aneuploidy.
    Wenstrom KD; Boots LR; Cosper PC
    J Matern Fetal Med; 1996; 5(1):31-5. PubMed ID: 8796763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Dual positivity' for neural tube defects and down syndrome at maternal serum screening: gestational outcome.
    Zanini R; Tarantini M; Cerri V; Jacobello C; Bellotti D; Lancetti S; Scalchi S; Groli C; Bianchi UA
    Fetal Diagn Ther; 1998; 13(2):106-10. PubMed ID: 9650657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum screening for neural tube defects and fetal chromosome abnormalities.
    Rose NC; Mennuti MT
    West J Med; 1993 Sep; 159(3):312-7. PubMed ID: 7694429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The triple-marker test in predicting fetal aneuploidy: a compromise between sensitivity and specificity.
    Huderer-Duric K; Skrablin S; Kuvacic I; Sonicki Z; Rubala D; Suchanek E
    Eur J Obstet Gynecol Reprod Biol; 2000 Jan; 88(1):49-55. PubMed ID: 10659916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of correlation between elevated maternal serum hCG during second-trimester biochemical screening and fetal congenital anomaly.
    Celentano C; Guanciali-Franchi PE; Liberati M; Palka C; Fantasia D; Morizio E; Calabrese G; Stuppia L; Rotmensch S
    Prenat Diagn; 2005 Mar; 25(3):220-4. PubMed ID: 15791663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening.
    Huang T; Owolabi T; Summers AM; Meier C; Wyatt PR
    Am J Obstet Gynecol; 2005 Aug; 193(2):395-403. PubMed ID: 16098861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Maternal serum screening for detection of fetal chromosome abnormalities].
    Holzgreve W; Miny P; Schloo R; Tercanli S
    Gynakologe; 1995 Oct; 28(5):280-8. PubMed ID: 7498824
    [No Abstract]   [Full Text] [Related]  

  • 18. Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus.
    Huttly W; Rudnicka A; Wald NJ
    Prenat Diagn; 2004 Oct; 24(10):804-7. PubMed ID: 15503275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy].
    Lesin J; Skrablin S; Durić K; Suchanek E; Muzinić D; Kalafatić D; Kuvacić I; Zlopasa G; Plavec A
    Lijec Vjesn; 2003; 125(3-4):55-60. PubMed ID: 12899094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?
    Sancken U; Bartels I
    Prenat Diagn; 2001 May; 21(5):383-6. PubMed ID: 11360279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.